{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T22:10:49Z","timestamp":1775859049949,"version":"3.50.1"},"reference-count":15,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24033","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T22:12:58Z","timestamp":1724969578000},"page":"252-260","source":"Crossref","is-referenced-by-count":3,"title":["&lt;i&gt;MYD88&lt;\/i&gt; mutation-positive indolent B-cell lymphoma with CNS involvement: Bing\u2013Neel syndrome mimickers"],"prefix":"10.3960","volume":"64","author":[{"given":"Kenichiro","family":"Takeda","sequence":"first","affiliation":[{"name":"Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"Minami","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihumi","family":"Ichiki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ichinomiya Nishi Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yamaga","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Nakajima","sequence":"additional","affiliation":[{"name":"ivision of Pathology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Varettoni M, Arcaini L, Zibellini S <i>et al.<\/i> Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom\u2019s macroglobulinemia and related lymphoid neoplasms. Blood. 2013; 121: 2522-2528.","DOI":"10.1182\/blood-2012-09-457101"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Martinez-Lopez A, Curiel-Olmo S, Mollejo M <i>et al.<\/i> MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol. 2015; 39: 644-651.","DOI":"10.1097\/PAS.0000000000000411"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Martinez-Trillos A, Pinyol M, Navarro A <i>et al.<\/i> Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome. Blood. 2014; 123: 3790-3796.","DOI":"10.1182\/blood-2013-12-543306"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Dogliotti I, Jimenez C, Varettoni M <i>et al.<\/i> Diagnostics in Waldenstrom\u2019s macroglobulinemia: a consensus statement of the European Consortium for Waldenstrom\u2019s Macroglobulinemia. Leukemia. 2023; 37: 388-395.","DOI":"10.1038\/s41375-022-01762-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Rossi D. Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis. Hematology Am Soc Hematol Educ Program. 2014; 2014: 113-118.","DOI":"10.1182\/asheducation-2014.1.113"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Treon SP, Xu L, Yang G <i>et al.<\/i> MYD88 L265P somatic mutation in Waldenstrom\u2019s macroglobulinemia. N Engl J Med. 2012; 367: 826-833.","DOI":"10.1056\/NEJMoa1200710"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lee MS, Sathe S, Valasapalli S, Grosse Perdekamp M. Bing-Neel Syndrome: An Initial Manifestation of Waldenstrom Macroglobulinemia. Cureus. 2021; 13: e19402.","DOI":"10.7759\/cureus.19402"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Garcia-Abellas P, Ferrer Gomez A, Bueno Sacristan D <i>et al.<\/i> Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: A diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis. EJHaem. 2022; 3: 1181-1187.","DOI":"10.1002\/jha2.573"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Minnema MC, Kimby E, D\u2019Sa S <i>et al.<\/i> Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica. 2017; 102: 43-51.","DOI":"10.3324\/haematol.2016.147728"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Simon L, Fitsiori A, Lemal R <i>et al.<\/i> Bing-Neel syndrome, a rare complication of Waldenstrom macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO). Haematologica. 2015; 100: 1587-1594.","DOI":"10.3324\/haematol.2015.133744"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Boiza-Sanchez M, Manso R, Balague O <i>et al.<\/i> Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution? PLoS One. 2020; 15: e0241634.","DOI":"10.1371\/journal.pone.0241634"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Hattori K, Sakata-Yanagimoto M, Suehara Y <i>et al.<\/i> Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Cancer Sci. 2018; 109: 225-230.","DOI":"10.1111\/cas.13450"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kikukawa Y, Yamamura-Fujimoto A, Endo S <i>et al.<\/i> Successful Treatment of Bing-Neel Syndrome Accompanying Waldenstrom\u2019s Macroglobulinemia with R-MPV: A Case Report. J Clin Exp Hematop. 2015; 55: 113-119.","DOI":"10.3960\/jslrt.55.113"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Narita Y, Nagane M, Mishima K <i>et al.<\/i> Phase I\/II study of tirabrutinib, a second-generation Bruton\u2019s tyrosine kinase inhibitor, in relapsed\/refractory primary central nervous system lymphoma. Neuro Oncol. 2021; 23: 122-133.","DOI":"10.1093\/neuonc\/noaa145"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Sekiguchi N. The Impact of Tirabrutinib Monotherapy for Bing-Neel Syndrome in Waldenstrom\u2019s Macroglobulinemia. Intern Med. 2022; 61: 3473-3474.","DOI":"10.2169\/internalmedicine.0041-22"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24033\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T05:06:27Z","timestamp":1727499987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/3\/64_24033\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24033","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24033"}}